MedTrace Logo

Mayo Designed Soft Tissue Ultrasound-Detectable Marker

NCT04674852 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2023-01-20

No results posted yet for this study

Summary

Researchers are trying to determine if the Mayo marker is easily seen with ultrasound making it easier, faster, and more accurate for preoperative localization of the biopsied positive lymph node.

Conditions

  • Breast Neoplasm Female
  • Ultrasound Therapy; Complications

Interventions

DEVICE

Research Marker

The research marker is a cylindrical-shaped marker made of an FDA-approved material that can be seen by ultrasound.

Sponsors & Collaborators

Principal Investigators

  • Christine Lee, MD, PhD · Mayo Clinic

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-02
Primary Completion
2021-07-26
Completion
2022-04-07
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04674852 on ClinicalTrials.gov